A novel strategy to reduce sudden death risk in the healing phase after myocardial infarction

Por Donahue, J. Kevin
Publicado em 2008

GENE THERAPY FOR VENTRICULAR TACHYARRHYTHMIAS

Por Donahue, J. Kevin
Publicado em 2012

Biological therapies for atrial fibrillation: ready for prime time?

Por Donahue, J. Kevin
Publicado no J Cardiovasc Pharmacol (2016)

Current state of the art for cardiac arrhythmia gene therapy

Por Donahue, J. Kevin
Publicado no Pharmacol Ther (2017)

Gene Therapy Strategies for Cardiac Electrical Dysfunction

Por Greener, Ian, Donahue, J. Kevin
Publicado em 2010

The Use of Gene Therapy for Ablation of Atrial Fibrillation

Por Liu, Zhao, Donahue, J Kevin
Publicado no Arrhythm Electrophysiol Rev (2014)

Gene Therapy to Treat Cardiovascular Disease

Por Wolfram, Julie A., Donahue, J. Kevin
Publicado em 2013

Connexin Remodeling Contributes to Atrial Fibrillation

Por Jennings, Michelle M, Donahue, J Kevin
Publicado no J Atr Fibrillation (2013)

Gene Therapy Approaches to Ventricular Tachyarrhythmias

Por Donahue, J. Kevin, Sasano, Tetsuo, Kelemen, Kamilla
Publicado em 2007

Information Learned from Animal Models of Atrial Fibrillation

Por Finet, J. Emanuel, Rosenbaum, David S., Donahue, J. Kevin
Publicado em 2009

Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy

Por Sasano, Tetsuo, Kelemen, Kamilla, Greener, Ian D., Donahue, J. Kevin
Publicado em 2009

Molecular Ablation of Ventricular Tachycardia after Myocardial Infarction

Por Sasano, Tetsuo, McDonald, Amy D., Kikuchi, Kan, Donahue, J. Kevin
Publicado em 2006

Ultrarapid, highly efficient viral gene transfer to the heart

Por Donahue, J. Kevin, Kikkawa, Kohei, Johns, David C., Marban, Eduardo, Lawrence, John H.
Publicado em 1997

Targeted High-Efficiency, Homogeneous Myocardial Gene Transfer

Por Sasano, Tetsuo, Kikuchi, Kan, McDonald, Amy D., Lai, Shenghan, Donahue, J. Kevin
Publicado em 2007

Selective molecular potassium channel blockade prevents atrial fibrillation

Por Guy, Amit, Kikuchi, Kan, Greener, Ian D., Yang, Lizhu, Novack, Victor, Donahue, J. Kevin
Publicado em 2010

Connexin43 Gene Transfer Reduces Ventricular Tachycardia Susceptibility After Myocardial Infarction

Por Greener, Ian D., Sasano, Tetsuo, Wan, Xiaoping, Igarashi, Tomonori, Strom, Maria, Rosenbaum, David S., Donahue, J. Kevin
Publicado em 2012

Phosphorylation at connexin43 serine-368 is necessary for myocardial conduction during metabolic stress

Por Nassal, Michelle MJ, Werdich, Andreas A., Wan, Xiaoping, Hoshi, Malcolm, Deschênes, Isabelle, Rosenbaum, David S., Donahue, J. Kevin
Publicado no J Cardiovasc Electrophysiol (2015)

Connexin Gene Transfer Preserves Conduction Velocity and Prevents Atrial Fibrillation

Por Igarashi, Tomonori, Finet, J. Emanuel, Takeuchi, Ayano, Fujino, Yoshihisa, Strom, Maria, Greener, Ian D., Rosenbaum, David S., Donahue, J. Kevin
Publicado em 2011

Addition of B-type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence after Pulmonary Vein Isolatio...

Por Shaikh, Amir Y., Esa, Nada, Martin-Doyle, William, Kinno, Menhel, Nieto, Iryna, Floyd, Kevin C., Browning, Clifford, Ennis, Cynthia, Donahue, J. Kevin, Rosenthal, Lawrence S., McManus, David D.
Publicado no Crit Pathw Cardiol (2015)

Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate

Por Ibrahim, Mohamed A, Do, Diana V, Sepah, Yasir J, Shah, Syed M, Van Anden, Elizabeth, Hafiz, Gulnar, Donahue, J Kevin, Rivers, Richard, Balkissoon, Jai, Handa, James T, Campochiaro, Peter A, Nguyen, Quan Dong
Publicado em 2013